Primolut N 5 mg Tablet.
PDF Leaflet Revision Date: 13 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Dysfunctional uterine bleeding, amenorrhoea, endometriosis.
Dosage (summary)
1 tablet 2-3 times daily for 10-14 days for menstruation delay; 1 tablet 3 times daily for 10 days for bleeding.
Onset of Action / Duration
Onset: 1-3 days, Duration: up to 30 tablets.
Special Populations
- Diabetes mellitus
- Obesity
- History of thromboembolic events
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Phenytoin
- Carbamazepine
- Rifampicin
- St. John's wort
Contraindications
- Hypersensitivity
- Pregnancy
- Lactation
- Thromboembolic history
- Severe hepatic disease
Common side effects
- Headache
- Nausea
- Spotting
- Depression
Counselling Points
- Use non-hormonal contraception
- Report mood changes
- Avoid sun exposure if prone to chloasma
Serious warnings
- Increased thromboembolic risk
- Monitor for mood changes
- Discontinue for severe headaches
Important Disclaimer
The Primolut N 5 mg Tablet. professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
